Broker Research
November 07, 2025 / 13:01 IST
Reported Consolidated quarterly numbers for Generic Pharmasec are:Net Sales at Rs 32.64 crore in September 2025 up 440.97% from Rs. 6.03 crore in September 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 1.18 crore in September 2025 down 267.15% from Rs. 0.70 crore in September 2024.
EBITDA stands negative at Rs. 0.01 crore in September 2025 down 101.15% from Rs. 0.87 crore in September 2024.
Generic Pharmas shares closed at 1.52 on November 06, 2025 (BSE) and has given -25.12% returns over the last 6 months and -50.33% over the last 12 months.
| Generic Pharmasec | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Sep'25 | Jun'25 | Sep'24 | | Net Sales/Income from operations | 32.64 | 12.04 | 6.03 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 32.64 | 12.04 | 6.03 | | EXPENDITURE | | Consumption of Raw Materials | 0.89 | 0.13 | 0.11 | | Purchase of Traded Goods | 39.78 | 10.75 | 5.36 | | Increase/Decrease in Stocks | -10.29 | -1.05 | -0.49 | | Power & Fuel | -- | -- | -- | | Employees Cost | 1.20 | 0.35 | 0.19 | | Depreciation | 0.56 | 0.27 | 0.30 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.54 | 0.92 | 0.73 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -1.04 | 0.67 | -0.17 | | Other Income | 0.46 | 0.69 | 0.75 | | P/L Before Int., Excpt. Items & Tax | -0.57 | 1.37 | 0.57 | | Interest | 0.23 | 0.12 | 0.07 | | P/L Before Exceptional Items & Tax | -0.80 | 1.25 | 0.50 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.80 | 1.25 | 0.50 | | Tax | 0.38 | 0.03 | -0.20 | | P/L After Tax from Ordinary Activities | -1.18 | 1.22 | 0.70 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -1.18 | 1.22 | 0.70 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -1.18 | 1.22 | 0.70 | | Equity Share Capital | 55.37 | 55.37 | 55.37 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.02 | 0.02 | 0.01 | | Diluted EPS | -0.02 | 0.02 | 0.01 | | EPS After Extra Ordinary | | Basic EPS | -0.02 | 0.02 | 0.01 | | Diluted EPS | -0.02 | 0.02 | 0.01 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
